Cover Image

Inflammation in Cachexia

Saved in:

Bibliographic Details
Main Authors:	M. Seelaender (Author), A. Laviano (Author), S. Busquets (Author), G. P. Püschel (Author), T. Margaria (Author), M. L. Batista (Author)
Format:	Book
Published:	Hindawi Limited, 2015-01-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Contribution of Neuroinflammation to the Pathogenesis of Cancer Cachexia
by: Alessio Molfino, et al.
Published: (2015)

Inflammation‐induced cholestasis in cancer cachexia
by: Morgane M. Thibaut, et al.
Published: (2021)

Nonmuscle Tissues Contribution to Cancer Cachexia
by: Josep M. Argilés, et al.
Published: (2015)

Therapeutic strategies against cancer cachexia
by: Josep M. Argilés, et al.
Published: (2019)

Nutrition in the spotlight in cachexia, sarcopenia and muscle: avoiding the wildfire
by: Carla M. Prado, et al.
Published: (2021)

Cancer Cachexia and MicroRNAs
by: Rodolfo Gonzalez Camargo, et al.
Published: (2015)

Cancer cachexia induces morphological and inflammatory changes in the intestinal mucosa
by: Raquel G.F. Costa, et al.
Published: (2019)

Inflammation‐associated intramyocellular lipid alterations in human pancreatic cancer cachexia
by: Min Deng, et al.
Published: (2024)

Tumour‐derived transforming growth factor‐β signalling contributes to fibrosis in patients with cancer cachexia
by: Joanna D.C.C. Lima, et al.
Published: (2019)

Prognostic value of systemic inflammation and for patients with colorectal cancer cachexia
by: Guo‐Tian Ruan, et al.
Published: (2023)

Cachexia causes time‐dependent activation of the inflammasome in the liver
by: Rodrigo Xavier dasNeves, et al.
Published: (2023)

Targeted medical nutrition for cachexia in chronic obstructive pulmonary disease: a randomized, controlled trial
by: Philip C. Calder, et al.
Published: (2018)

Effects of S‐pindolol in mouse pancreatic and lung cancer cachexia models
by: Jochen Springer, et al.
Published: (2023)

The atypical β‐blocker S‐oxprenolol reduces cachexia and improves survival in a rat cancer cachexia model
by: Luping Yuan, et al.
Published: (2023)

The prognostic value of the combination of body composition and systemic inflammation in patients with cancer cachexia
by: Hai‐Lun Xie, et al.
Published: (2023)

Impairment of aryl hydrocarbon receptor signalling promotes hepatic disorders in cancer cachexia
by: Adeline Dolly, et al.
Published: (2023)

Therapeutic Approaches in Mitochondrial Dysfunction, Inflammation, and Autophagy in Uremic Cachexia: Role of Aerobic Exercise
by: Yumei Zhang, et al.
Published: (2019)

Mapping ongoing nutrition intervention trials in muscle, sarcopenia, and cachexia: a scoping review of future research
by: Camila E. Orsso, et al.
Published: (2022)

Lipopolysaccharide‐induced hypothalamic inflammation in cancer cachexia‐anorexia is amplified by tumour‐derived prostaglandin E2
by: Xiaolin Li, et al.
Published: (2022)

Inflammation in Disease: Mechanism and Therapies
by: Gustavo Duarte Pimentel, et al.
Published: (2013)

Inflammation in the Disease: Mechanism and Therapies 2014
by: M. Seelaender, et al.
Published: (2015)

Geriatric Nutrition Risk Index: Prognostic factor related to inflammation in elderly patients with cancer cachexia
by: Guo‐Tian Ruan, et al.
Published: (2021)

Association of Systemic Inflammation and Overall Survival in Elderly Patients with Cancer Cachexia – Results from a Multicenter Study
by: Ruan GT, et al.
Published: (2021)

Oral Equilibrium in Cachexia
by: Deepthi Darwin, et al.
Published: (2021)

Cachexia and advanced dementia
by: Cecilia Minaglia, et al.
Published: (2019)

Administration of adiponectin receptor agonist AdipoRon relieves cancer cachexia by mitigating inflammation in tumour‐bearing mice
by: Isabelle S. Massart, et al.
Published: (2024)

A multi‐targeted treatment approach to cancer cachexia: Auckland's Cancer Cachexia evaluating Resistance Training (ACCeRT) trial
by: Elaine S. Rogers, et al.
Published: (2020)

Cancer cachexia: an orphan with a future
by: Mitja Lainscak, et al.
Published: (2019)

Handelin alleviates cachexia‐ and aging‐induced skeletal muscle atrophy by improving protein homeostasis and inhibiting inflammation
by: Hui‐Jie Zhang, et al.
Published: (2024)

Association of systemic inflammation with survival in patients with cancer cachexia: results from a multicentre cohort study
by: Qi Zhang, et al.
Published: (2021)

Lenalidomide in cancer cachexia: a randomized trial of an anticancer drug applied for anti‐cachexia
by: David Blum, et al.
Published: (2022)

Quality of life endpoints in cancer cachexia clinical trials: Systematic review 3 of the cachexia endpoints series
by: Marianne J. Hjermstad, et al.
Published: (2024)

Biomarker endpoints in cancer cachexia clinical trials: Systematic Review 5 of the cachexia endpoint series
by: Michael S. Yule, et al.
Published: (2024)

Diagnosis and outcomes of cachexia in Asia: Working Consensus Report from the Asian Working Group for Cachexia
by: Hidenori Arai, et al.
Published: (2023)

Special Issue on Cancer Cachexia
by: Susan Mcclement
Published: (2018)

Cancer cachexia: the elephant in the room?
by: Eric J. Roeland
Published: (2022)

Cancer as a Proinflammatory Environment: Metastasis and Cachexia
by: Nelson Inácio Pinto, et al.
Published: (2015)

Physical function endpoints in cancer cachexia clinical trials: Systematic Review 1 of the cachexia endpoints series
by: James McDonald, et al.
Published: (2023)

Body weight and composition endpoints in cancer cachexia clinical trials: Systematic Review 4 of the cachexia endpoints series
by: Leo R. Brown, et al.
Published: (2024)

Hand grip strength‐based cachexia index as a predictor of cancer cachexia and prognosis in patients with cancer
by: Hailun Xie, et al.
Published: (2023)